BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol. 2001;46:366-368. [PMID: 11712766 DOI: 10.1034/j.1600-0897.2001.d01-25.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Borrego L. Etanercept en el embarazo y lactancia. Actas Dermo-Sifiliográficas 2010;101:97-101. [DOI: 10.1016/s0001-7310(10)70016-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255-1258. [PMID: 17045211 DOI: 10.1016/j.cgh.2006.07.018] [Cited by in Crossref: 198] [Cited by in F6Publishing: 163] [Article Influence: 14.1] [Reference Citation Analysis]
3 Pham T, Bachelez H, Berthelot JM, Blacher J, Bouhnik Y, Claudepierre P, Constantin A, Fautrel B, Gaudin P, Goëb V, Gossec L, Goupille P, Guillaume-Czitrom S, Hachulla E, Huet I, Jullien D, Launay O, Lemann M, Maillefert JF, Marolleau JP, Martinez V, Masson C, Morel J, Mouthon L, Pol S, Puéchal X, Richette P, Saraux A, Schaeverbeke T, Soubrier M, Sudre A, Tran TA, Viguier M, Vittecoq O, Wendling D, Mariette X, Sibilia J. TNF alpha antagonist therapy and safety monitoring. Joint Bone Spine 2011;78 Suppl 1:15-185. [PMID: 21703545 DOI: 10.1016/S1297-319X(11)70001-X] [Cited by in Crossref: 53] [Cited by in F6Publishing: 6] [Article Influence: 5.3] [Reference Citation Analysis]
4 Sharma UR, Nediyedath Rathnakaran A, Raj BPP, Padinjakkara G, Das A, Vada S, Mudagal MP. The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy. Inflammopharmacology 2021;29:987-1000. [PMID: 33844107 DOI: 10.1007/s10787-021-00808-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rump JA, Schönborn H. [Conception and course of eight pregnancies in five women on TNF blocker etanercept treatment]. Z Rheumatol. 2010;69:903-909. [PMID: 20532789 DOI: 10.1007/s00393-010-0652-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
6 Berthelot JM, De Bandt M, Goupille P, Solau-Gervais E, Lioté F, Goeb V, Azaïs I, Martin A, Pallot-Prades B, Maugars Y. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine. 2009;76:28-34. [PMID: 19059799 DOI: 10.1016/j.jbspin.2008.04.016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
7 Sioulas VD, Gracia CR. Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: Is it safe? J Assist Reprod Genet 2012;29:271-5. [PMID: 22205344 DOI: 10.1007/s10815-011-9697-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Cobo-Ibáñez T, Martín-Mola E. Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis. Expert Opin Pharmacother 2007;8:1373-97. [PMID: 17563271 DOI: 10.1517/14656566.8.9.1373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
9 Khanna D, Mcmahon M, Furst DE. Safety of Tumour Necrosis Factor-?? Antagonists: . Drug Safety 2004;27:307-24. [DOI: 10.2165/00002018-200427050-00003] [Cited by in Crossref: 138] [Cited by in F6Publishing: 108] [Article Influence: 8.1] [Reference Citation Analysis]
10 Katz JA. Pregnancy and inflammatory bowel disease: . Current Opinion in Gastroenterology 2004;20:328-32. [DOI: 10.1097/00001574-200407000-00005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
11 Gurtcheff S, Hatasaka H. Fertility and Autoimmune Disease. Reproductive and Hormonal Aspects of Systemic Autoimmune Diseases. Elsevier; 2005. pp. 29-42. [DOI: 10.1016/s1571-5078(05)04004-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Florea A, Job-Deslandre C. [Rheumatoid arthritis and pregnancy]. Presse Med 2008;37:1644-51. [PMID: 18819772 DOI: 10.1016/j.lpm.2008.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-melton M, Outman R, Allison JJ, Almazor MS, Bridges SL, Chatham WW, Hochberg M, Maclean C, Mikuls T, Moreland LW, O'dell J, Turkiewicz AM, Furst DE. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84. [DOI: 10.1002/art.23721] [Cited by in Crossref: 986] [Cited by in F6Publishing: 746] [Article Influence: 75.8] [Reference Citation Analysis]
14 Lockshin MD. Assisted reproductive technologies for women with rheumatic AID. Best Pract Res Clin Obstet Gynaecol 2020;64:85-96. [PMID: 31791669 DOI: 10.1016/j.bpobgyn.2019.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Youssef P, Kennedy D. Arthritis in pregnancy: the role and safety of biological agents. Obstet Med 2009;2:134-7. [PMID: 27579057 DOI: 10.1258/om.2009.090023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Dubertret L, Chimenti S, Christophers E, Daudén E, de Rie M, Griffiths CEM, Kragballe K, Ståhle M, Stingl G. Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts. British Journal of Dermatology 2009;161:1-30. [DOI: 10.1111/j.1365-2133.2009.09173.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Abdolmohammadi-vahid S, Danaii S, Hamdi K, Jadidi-niaragh F, Ahmadi M, Yousefi M. Novel immunotherapeutic approaches for treatment of infertility. Biomedicine & Pharmacotherapy 2016;84:1449-59. [DOI: 10.1016/j.biopha.2016.10.062] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
18 Salmon JE, Alpert D. Are we coming to terms with tumor necrosis factor inhibition in pregnancy? Arthritis Rheum 2006;54:2353-5. [DOI: 10.1002/art.22027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
19 Natsumi I, Matsukawa Y, Miyagawa K, Kodaira H, Tanaka T, Horikoshi A, Takeuchi J, Takei M, Maejima M, Akimoto J. Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment. Rheumatol Int 2013;33:2433-5. [DOI: 10.1007/s00296-012-2433-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Mena-vazquez N. Safety of biologic therapies during pregnancy in women with rheumatic disease. WJR 2015;5:82. [DOI: 10.5499/wjr.v5.i2.82] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Kane S. Inflammatory bowel disease in pregnancy. Gastroenterology Clinics of North America 2003;32:323-40. [DOI: 10.1016/s0889-8553(02)00068-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
22 Aslanidis S, Pyrpasopoulou A, Douma S, Poulakos P, Triantafyllou A. Restoration of menstruation in premature ovarian failure after initiation of adalimumab. Scandinavian Journal of Rheumatology 2009;37:488-90. [DOI: 10.1080/03009740802241733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Temprano KK, Bandlamudi R, Moore TL. Antirheumatic Drugs in Pregnancy and Lactation. Seminars in Arthritis and Rheumatism 2005;35:112-21. [DOI: 10.1016/j.semarthrit.2005.05.002] [Cited by in Crossref: 96] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
24 Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol. 2008;14:3085-3087. [PMID: 18494064 DOI: 10.3748/wjg.14.3085] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
25 Micheloud D, Nuño L, Rodríguez-mahou M, Sánchez-ramón S, Ortega MC, Aguarón A, Junco E, Carbone J, Fernández-cruz E, Carreño L, López-longo FJ. Efficacy and safety of Etanercept, high-dose intravenous gammaglobulin and plasmapheresis combined therapy for lupus diffuse proliferative nephritis complicating pregnancy. Lupus 2006;15:881-5. [DOI: 10.1177/0961203306070970] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
26 Lioté F. Médicaments rhumatologiques autorisés pendant la grossesse. Revue du Rhumatisme 2005;72:755-60. [DOI: 10.1016/j.rhum.2005.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chambers CD, Tutuncu ZN, Johnson D, Jones KL. Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther. 2006;8:215. [PMID: 16774693 DOI: 10.1186/ar1977] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]